14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
STOK vs ANNX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Stoke Therapeutics, Inc. (STOK) is the stronger overall head-to-head candidate over Annexon, Inc. (ANNX) in the Tradestie Institutional Equity Comparison Engine, winning 6–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). STOK carries a Unified Composite Score of 56.7/100 (HOLD) at $26.54 (N/M Forward P/E, -913.2% operating margin), whereas ANNX carries 44.6/100 (HOLD) at $3.58 (N/M Forward P/E, 0.0% operating margin).
Technical & Structure Timing Caution: STOK trades in a Neutral technical trend (SURGE options phase, RSI 50.5); meanwhile ANNX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on STOK vs ANNX. Trailing 12-month operating profitability (STOK -913.2% vs ANNX 0.0%) and valuation multiples (STOK N/M vs ANNX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Biotechnology value chain with $757.3M market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ STOK vs ANNX Key Questions & Quantitative Answers
As of Nov 16, 2026, Stoke Therapeutics, Inc. (STOK) is the stronger overall head-to-head candidate over Annexon, Inc. (ANNX) in the Tradestie Institutional Equity Comparison Engine, winning 6–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). STOK carries a Unified Composite Score of 56.7/100 (HOLD) at $26.54 (N/M Forward P/E, -913.2% operating margin), whereas ANNX carries 44.6/100 (HOLD) at $3.58 (N/M Forward P/E, 0.0% operating margin). Technical & Structure Timing Caution: STOK trades in a Neutral technical trend (SURGE options phase, RSI 50.5); meanwhile ANNX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
STOK leads the Growth & Scale pillar: STOK posts +5.9% YoY revenue growth and +0.0% YoY earnings growth on $28M TTM revenue (100.0% gross margin, -913.2% operating margin), compared with ANNX at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, STOK generates $28M in USD-normalized revenue versus N/A for ANNX. In operating R&D and SG&A reinvestment, STOK deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ANNX.
STOK screens cheaper on headline valuation multiples. STOK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 57.0x EV/Revenue (unreported FCF margin), whereas ANNX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against STOK (-73.6% ROE) versus ANNX (-130.8% ROE) capital efficiency.
In options market volatility and institutional positioning, STOK carries 63.5% implied volatility (8th %ile, Compressed (<25th %ile)), a 3.80x (Put-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a SURGE options structure phase (0.99β · 47% Vol realized risk). By comparison, ANNX carries 209.2% implied volatility (40th %ile, Balanced (25th–60th %ile)), a 0.75x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.68β · 62% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.